Pfizer safe for children

According to the Wall Street Journal, Pfizer and BioNTech announced Wednesday that their COVID-19 vaccine is 100% effective in preventing symptomatic disease in children aged 12 to 15. The report is based on a study of over 2,000 children. The companies will ask U.S. health regulators for authorization to vaccinate children, hoping to vaccinate most before September.